⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRVS News
Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2025 Financial Results
globenewswire.com
CRVS
Corvus Pharmaceuticals to Present Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial at the 67th American Society of Hematology Annual Meeting & Exposition
globenewswire.com
CRVS
Corvus Pharmaceuticals to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
globenewswire.com
CRVS
Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2025 Financial Results on November 4, 2025
globenewswire.com
CRVS
Corvus Pharmaceuticals Announces Presentation of Interim Data from the Phase 1b/2 Clinical Trial of Ciforadenant for Patients with Metastatic Renal Cell Cancer at the European Society for Medical Oncology (ESMO) Congress 2025
globenewswire.com
CRVS
Corvus Pharmaceuticals Appoints David Moore to Board of Directors
globenewswire.com
CRVS